Unknown

Dataset Information

Frequency of genomic secondary findings among 21,915 eMERGE network participants.


ABSTRACT:

Purpose

Discovering an incidental finding (IF) or secondary finding (SF) is a potential result of genomic testing, but few data exist describing types and frequencies of SFs likely to appear in broader clinical populations.

Methods

The Electronic Medical Records and Genomics Network Phase III (eMERGE III) developed a CLIA-compliant sequencing panel of 109 genes and 1551 variants of clinical relevance or research interest and deployed this panel at ten clinical sites. We evaluated medically actionable SFs across 67 genes and 14 single-nucleotide variants (SNVs) in a diverse cohort of 21,915 participants drawn from a variety of settings (e.g., primary care, biobanks, specialty clinics).

Results

Correcting for testing indication, we found a 3.02% overall frequency of SFs

SUBMITTER: eMERGE Clinical Annotation Working Group 

PROVIDER: S-EPMC7713503 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature